Premium accounts now available! Sign up and create a premium account. Read more Close

Advertisement

Image

Evorpacept plus trastuzumab, ramucirumab and paclitaxel in HER2-positive gastric cancer: a randomized phase 2 trial

Journal content Created on 24 Sep 2026 Nature Medicine

Keun-Wook Lee

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 27
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement